Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

Matched clinical trials

  • Study of GHZ339 for treatment of moderate to severe atopic dermatitis

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Hungary Italy The Netherlands +3
  • Study on the Safety and Effectiveness of Upadacitinib and Dupilumab for Children Aged 2 to 12 with Moderate to Severe Atopic Dermatitis

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria Bulgaria Croatia France Germany Hungary +6
  • Pharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Poland
  • Study of Camoteskimab and Sodium Chloride Placebo in Adults with Moderate-to-Severe Atopic Dermatitis

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Germany Hungary Poland Spain
  • Phase 2b Randomized Double‑Blind Study of Oral PF‑08049820 in Adults with Moderate to Severe Atopic Dermatitis

    Not yet recruiting

    2 1
    Bulgaria Czechia France Germany Poland
  • A Study of Lebrikizumab for Adults and Adolescents with Moderate to Severe Atopic Dermatitis to Evaluate Effects on Eczema and Skin Barrier Function

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Sweden
  • Testing GIA632 compared to placebo in adults with moderate to severe atopic dermatitis to measure effectiveness and safety

    Not yet recruiting

    2 1
    Investigated Diseases:
    Bulgaria Czechia France Germany Poland
  • Study of Lebrikizumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis to Understand How the Medicine Works

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • Study to evaluate ATI-045 injection compared to placebo in adults with moderate to severe atopic dermatitis

    Not yet recruiting

    2 1
    Investigated Diseases:
    Czechia Germany Poland
  • Study of IMG-007 injection to treat moderate to severe atopic dermatitis in adults

    Not yet recruiting

    2 1
    Investigated Drugs:
    Czechia Germany Hungary Poland Spain